Legion Creatine Review: Does Recharge Add More Than 5 g of Creatine?

Verdict: the creatine dose is supported as a label fact, not the complete product outcome

The strongest verified feature of Recharge is simple.

Legion lists 5 grams of creatine monohydrate per serving on the official Recharge Post-Workout page.

The supplied study also used 5 grams of creatine monohydrate.

This creates a direct match for creatine form and amount.

The connection ends there.

Recharge contains two additional listed ingredients. The study used different co-ingested nutrients and did not administer Recharge. It therefore cannot establish what the finished powder does.

The practical verdict depends on what a reader wants from the product.

Recharge may remain relevant to someone who specifically wants its documented combination in powder form.

It is a weak evidence fit for someone who requires proof that the combination works better than creatine alone.

It is also a weak fit for someone buying primarily because the words Post-Workout appear in the name. The supplied timing study did not find an additional influence from taking creatine before rather than after training on the outcomes it measured.

That result is narrow. It applies to the tested timing windows, population, dose, and eight-week protocol.

It does not settle every creatine-timing question.

It also does not establish that Recharge fails to work. No finished-product outcome trial was supplied in either direction.

The evidence supports a limited conclusion: Recharge lists a study-matched creatine serving inside a formula whose complete effects remain untested in this packet.

What one serving of Recharge actually establishes

This review covers Legion Athletics Recharge Post-Workout powder.

It does not cover every product sold under the Legion brand. It also does not treat Recharge as interchangeable with a single-ingredient creatine powder.

The verified formula snapshot is specific:

Listed ingredient	Amount per serving	What is established
Creatine monohydrate	5 g	Ingredient identity, form, and amount
L-carnitine L-tartrate	2.1 g	Ingredient identity, form, and amount
Corosolic acid	10.5 mg	Ingredient identity and amount

These figures come from the official product evidence accessed on August 30, 2026.

They establish what Legion Athletics lists in one serving.

They do not show that the ingredients produced a particular result.

They do not show that the three ingredients were clinically tested together.

The supplied evidence does not show that either addition improves the effect of the creatine component.

This distinction is central to the buying decision.

A reader interested in Recharge is not choosing only a 5-gram creatine dose. The reader is considering that dose inside a powder that also contains 2.1 grams of L-carnitine L-tartrate and 10.5 milligrams of corosolic acid.

The packet supplies outcome evidence only for a creatine-timing protocol.

It supplies no matching outcome study for the other two listed ingredients.

That does not prove those ingredients are ineffective.

It means their contribution to Recharge cannot be determined from the supplied evidence.

The label is therefore more complete than the outcome evidence.

That is the defining limitation of this product review.

The real buying choice: Recharge’s combination or a creatine-only approach

Recharge’s composition makes the decision more specific than asking whether someone wants creatine.

The powder includes creatine monohydrate plus two other listed ingredients.

A person who wants that exact combination may consider the format convenient. The packet does not contain evidence about convenience, preference, or adherence, so those remain personal considerations rather than verified benefits.

A person who wants only creatine monohydrate faces a different question.

Does the packet show that Recharge’s added L-carnitine L-tartrate and corosolic acid provide an advantage over plain creatine?

It does not.

No supplied study compares Recharge with creatine alone.

No supplied study tests whether 2.1 grams of L-carnitine L-tartrate changes the effect of the 5-gram creatine serving.

No supplied study tests whether 10.5 milligrams of corosolic acid changes that effect.

There is also no verified price or serving count.

The packet therefore cannot support a comparison of cost per serving or cost per gram of creatine.

The evidence does not justify saying that Recharge is a better value, a worse value, or a more effective formula than a creatine-only product.

The supplied evidence supports a simpler decision rule.

Choose based on whether the documented three-ingredient composition is what you want, while recognizing that the packet does not establish an added outcome from the two non-creatine ingredients.

If proof of superiority is required, this packet does not provide it.

How closely the creatine study matches Recharge

Study relevance depends on more than finding the same ingredient name.

The form, amount, population, timing, duration, and complete intervention all matter.

For Recharge, two factors match directly. Several others do not.

Fit factor	Supplied study	Recharge	Assessment
Creatine form	Creatine monohydrate	Creatine monohydrate	Direct match
Creatine amount	5 g per assigned creatine dose	5 g per serving	Direct match
Timing	Within 1 hour before or after training	Product is named Post-Workout; captured directions were not supplied	Limited relevance
Other substances	25 g whey protein isolate and 25 g maltodextrin with each assigned dose	2.1 g L-carnitine L-tartrate and 10.5 mg corosolic acid	Material mismatch
Population	34 healthy, resistance-trained male and female collegiate athletes	Intended user population was not established in the supplied facts	Cannot match
Duration	8 weeks	A matching product-use duration was not supplied	Cannot match
Finished product	Recharge was not administered	Three-ingredient Recharge powder	No match

The form-and-amount match makes the study relevant to Recharge’s creatine component.

It does not make the study a Recharge trial.

The full intervention was materially different.

Participants co-ingested 25 grams of whey protein isolate and 25 grams of maltodextrin with each assigned dose. Recharge instead lists L-carnitine L-tartrate and corosolic acid alongside creatine.

The study population also limits interpretation.

It included 34 healthy, resistance-trained male and female collegiate athletes matched according to fat-free mass.

The results cannot automatically be extended to every age, health status, training background, schedule, or goal.

The eight-week duration adds another boundary.

The packet does not support assuming the same findings after a shorter period or over a longer period.

The useful takeaway is precise.

The study is a reasonable source for discussing 5 grams of creatine monohydrate in the tested timing protocol. It is not direct evidence for Recharge’s complete composition.

Does the Post-Workout name imply a special timing advantage?

No special timing advantage is established by the supplied evidence.

The primary study record describes a randomized, double-blind, placebo-controlled, parallel study.

Randomized means participants were assigned to groups by chance.

Double-blind means participants and the relevant researchers did not know the treatment assignments during the study.

Placebo-controlled means an inactive comparison treatment was used.

Parallel means participants remained in their assigned groups instead of receiving each intervention in sequence.

The study involved 34 healthy, resistance-trained male and female collegiate athletes over eight weeks.

One creatine group took 5 grams of creatine monohydrate within one hour before training.

Another took 5 grams within one hour after training.

Participants also consumed 25 grams of whey protein isolate and 25 grams of maltodextrin with each assigned dose.

All groups had similar statistically significant changes in fat-free mass, strength, body mass, fat mass, and body fat.

Statistically significant means a result met the study’s statistical threshold. It does not automatically mean the change was large, important to every athlete, or caused by Recharge.

The central timing finding was that creatine timing had no additional influence on the measured outcomes.

Within this protocol, the post-workout window did not show an added influence over the tested alternatives.

The wording must remain narrow.

The study did not test every time of day or every possible schedule.

It did not establish that timing never matters under any conditions.

Its abstract states that research comparing pre-workout and post-workout creatine administration is limited.

It also did not test Recharge.

The product name may make the after-training period feel central. The supplied evidence does not turn that positioning into proof of timing superiority.

Nor does the study show that a post-workout routine is useless. Convenience and routine preference were not established outcomes in the packet.

The defensible conclusion is that immediate post-workout use is not shown here to provide a unique advantage.

Actual use should follow the current product directions, which must be checked separately because a complete use protocol was not supplied.

What the two added ingredients contribute to the evidence record

Recharge lists 2.1 grams of L-carnitine L-tartrate per serving.

It also lists 10.5 milligrams of corosolic acid.

Those are verified composition facts.

The packet provides no outcome study for either ingredient at Recharge’s listed amount.

It also provides no trial of either ingredient as part of the complete Recharge formula.

This creates two unanswered questions.

First, the packet cannot establish what 2.1 grams of L-carnitine L-tartrate contributes to Recharge.

Second, it cannot establish what 10.5 milligrams of corosolic acid contributes.

The evidence gap should not be turned into a negative finding.

Absence of a supplied study is not proof that an ingredient has no effect.

It is also not permission to assume a benefit from the ingredient’s presence.

The same boundary applies to combination claims.

The packet does not show that these ingredients complement creatine.

The supplied evidence does not show that the combination improves strength, body composition, soreness, or recovery beyond creatine alone.

It does not establish a mechanism for the finished product.

Recharge’s evidence record is therefore uneven by ingredient:

Formula component	Evidence available in this packet
5 g creatine monohydrate	Verified label amount plus a timing study using the same form and amount
2.1 g L-carnitine L-tartrate	Verified label identity and amount only
10.5 mg corosolic acid	Verified label identity and amount only

This separation matters because evidence for creatine cannot silently be assigned to every ingredient in the scoop.

The powder must be judged as the formula Legion lists, while the study must remain attached to the specific intervention researchers tested.

Claims the packet supports—and claims it does not

The packet supports several concrete statements.

Recharge is a powder sold as Legion Recharge Post-Workout.

Legion lists 5 grams of creatine monohydrate, 2.1 grams of L-carnitine L-tartrate, and 10.5 milligrams of corosolic acid per serving.

The supplied study used the same creatine form and amount.

The study lasted eight weeks and involved 34 healthy, resistance-trained male and female collegiate athletes.

Creatine timing had no additional influence on the outcomes measured in that protocol.

The packet does not support stronger product claims.

It does not show that Recharge was clinically tested as a finished product.

It does not show that Recharge works better than plain creatine.

It does not show that its three ingredients work better together.

It does not establish a unique advantage from taking Recharge after training.

The supplied evidence does not establish that Recharge reduces soreness.

It does not establish instant recovery or guaranteed next-day readiness.

It does not guarantee an improvement in strength or body composition.

The study reported measures including strength and body composition, but Recharge was not the tested intervention.

The packet also does not establish universal safety.

General supplement guidance cannot prove that a particular product is safe for every person.

This boundary is not a technicality.

It changes the answer to the main search question.

Recharge has a verified formula and a study-relevant creatine component. It does not have verified finished-product efficacy in the supplied evidence.

Price, servings, directions, and guarantee remain open questions

A useful product review must identify missing buying information instead of estimating it.

In the supplied evidence packet, the following details are absent:

• Price

• Serving count

• Cost per serving

• Shipping cost

• Subscription terms

• Guarantee or return period

• Live availability

• Complete product directions

These omissions prevent a full value judgment.

Without a price and serving count, the cost of each 5-gram creatine serving cannot be calculated.

Without comparable commercial information, Recharge cannot be fairly ranked against a creatine-only option.

Without a captured guarantee or return period, no risk-reversal claim can be made.

Without complete directions, the study protocol should not be presented as the product’s usage instructions.

The official product evidence was accessed on August 30, 2026. That date is a research snapshot, not a promise that future details will remain unchanged.

Before ordering, check the official Recharge page for the current label, directions, warnings, price, serving information, availability, and purchase terms.

Any price, discount, subscription offer, or return condition found there should be treated as current only for the date on which it is checked.

Safety context and practical cautions

The packet does not establish that Recharge is appropriate for everyone.

The National Center for Complementary and Integrative Health guidance provides general context for bodybuilding and performance-enhancement supplements.

The National Center for Complementary and Integrative Health is abbreviated as NCCIH.

NCCIH states that some dietary supplements may interact with drugs or other supplements.

It also states that some vitamins and minerals can be harmful at high doses.

That statement about vitamins and minerals is general guidance. It is not a finding about Recharge’s listed ingredients.

NCCIH advises talking with a health care provider before using a dietary supplement for bodybuilding or endurance.

This guidance does not show that Recharge caused a specific adverse effect.

It also does not guarantee that Recharge is safe for a particular person.

Someone taking medication, using several supplements, or managing an individual health concern should bring the current product label to a qualified health care provider.

The current directions and warnings should also be reviewed before use.

The packet does not contain enough product-specific safety evidence to replace that individual assessment.

Who Recharge fits based on the evidence supplied

Recharge may fit someone who wants all three listed ingredients in one powder.

That person should be comfortable with the evidence split across the formula.

The creatine component has a relevant timing study using the same form and amount.

The L-carnitine L-tartrate and corosolic acid components have verified label amounts but no supplied outcome evidence.

Recharge may also fit someone who prefers a product presented for post-workout use, as long as that preference is not mistaken for proof of timing superiority.

The packet does not establish that taking it after training produces a unique effect.

Recharge may not fit someone who wants only creatine monohydrate without other listed ingredients.

It may not fit someone who requires a controlled trial of the exact finished product.

It may not fit someone whose purchase depends on proof that the additions outperform plain creatine.

It may also be difficult to assess for someone who needs a confirmed price, serving count, guarantee, or subscription comparison before deciding.

Those commercial details are absent.

A focused decision check is useful:

1. Do you want the complete listed combination rather than creatine alone?

2. Are you comfortable that the supplied human study applies only to the creatine component?

3. Do you accept that the packet shows no added efficacy from L-carnitine L-tartrate or corosolic acid?

4. Are you willing to verify the current directions, warnings, price, and terms separately?

If the answer to any of these questions is no, the supplied evidence does not make Recharge an obvious choice.

The VSL Strategy We Would Test for Legion Recharge Post-Workout

This is Daily Intel’s original proposed strategy.

It is not a script, video, advertisement, or video sales letter that Legion Athletics is known to have used.

A video sales letter is abbreviated as VSL.

No manufacturer campaign, customer response, conversion rate, testimonial, sales result, or first-hand product experience is claimed.

We would call the concept The Three-Label Test.

The creative goal would be to answer the question hidden inside Recharge’s formula: which parts are verified label facts, which part connects with a human study, and which conclusions remain unsupported?

Hook

The opening would show one scoop divided into three clean ingredient callouts.

The narrator would ask:

“Recharge contains 5 grams of creatine monohydrate—but do its other two listed ingredients make the finished powder more effective, and does taking it after training create a proven advantage?”

This hook starts with the actual product decision.

It does not promise a transformation.

It does not invent a hidden cause of poor performance.

It does not suggest that a trainee will lose progress by missing a narrow timing window.

Lead

The lead would set a compact evidence agenda:

“We will check three labels. First, what Legion lists in one serving. Second, what the supplied creatine study actually tested. Third, what remains unknown about the complete Recharge formula.”

The screen would then show the three verified amounts: 5 grams, 2.1 grams, and 10.5 milligrams.

The narrator would attribute the formula to Legion Athletics.

The lead would explain that a label verifies composition, not results.

That distinction would become the organizing idea for the entire execution.

Story

The story would follow a fictional decision, not a fictional testimonial.

A resistance-trained shopper sees the words Recharge and Post-Workout.

Three possible conclusions appear on screen.

The first is: “The powder must work best immediately after training.”

The second is: “Every ingredient in the scoop must share the evidence associated with creatine.”

The third is: “More listed ingredients must mean better results than plain creatine.”

The narrator would pause after each statement and ask what evidence would be needed to support it.

The character would not report using the product.

No change in strength, soreness, recovery, appearance, or body composition would be attributed to the character.

The story’s resolution would come from examining the packet rather than inventing a buyer outcome.

Mechanism

The mechanism section would describe how the evidence fits the formula.

It would not invent a biological mechanism for Recharge.

The first card would show the official serving information:

• 5 grams of creatine monohydrate

• 2.1 grams of L-carnitine L-tartrate

• 10.5 milligrams of corosolic acid

The narrator would say:

“This tells us what Legion lists per serving. It does not show what the ingredients produced together.”

The second card would display the supplied study protocol.

Thirty-four healthy, resistance-trained male and female collegiate athletes participated for eight weeks.

The creatine groups used 5 grams of creatine monohydrate within one hour before or within one hour after training.

Participants also consumed 25 grams of whey protein isolate and 25 grams of maltodextrin with each assigned dose.

Two green match markers would appear beside creatine monohydrate and 5 grams.

Then three boundary markers would appear.

The first would identify the different co-ingested nutrients.

The second would note that Recharge’s L-carnitine L-tartrate and corosolic acid combination was not tested.

The third would state that Recharge itself was not the administered product.

The narrator would explain:

“The creatine form and amount match. The complete intervention does not. That makes the study relevant to one part of the scoop, not proof for the finished powder.”

Each ingredient would then receive its own evidence label.

Creatine monohydrate would be marked: label verified; matching form and amount studied in a different protocol.

L-carnitine L-tartrate would be marked: label identity and amount verified; no supplied outcome study.

Corosolic acid would receive the same bounded label.

This treatment would stop evidence for creatine from flowing into the other two ingredients without support.

Proof

The proof segment would begin with the primary study rather than a testimonial or expert endorsement.

The design would be described in plain language.

Participants were assigned to groups by chance. An inactive placebo comparison was included. The study used concealed treatment assignments and parallel groups.

The study reported similar statistically significant changes across all groups in fat-free mass, strength, body mass, fat mass, and body fat.

The narrator would explain that statistical significance means a result met the study’s statistical threshold. It does not automatically mean a large effect, an important effect for every athlete, or an effect caused by Recharge.

The central result would then appear:

“In this eight-week protocol, creatine timing had no additional influence on the measured outcomes.”

A second line would preserve the limitation:

“The abstract says research comparing pre-workout and post-workout creatine use is limited.”

The product would then return to the screen.

The proof segment would state that the study supports discussion of a matching creatine form and amount under its tested protocol.

It would not say the study proves Recharge improves strength, body composition, soreness, or recovery.

No customer count, rating, testimonial, endorsement, or finished-product trial would appear because none was supplied.

Objections

The first objection would be: “Do I lose a proven benefit if I do not take it immediately after training?”

The answer would be no such loss is established by the supplied evidence.

The study compared 5 grams of creatine monohydrate within one hour before training with the same amount within one hour after training. Timing had no additional influence on the measured outcomes.

The answer would remain tied to that protocol. It would also direct viewers to follow the product’s current directions.

The second objection would be: “Were all three Recharge ingredients tested together?”

The answer would be no.

The study used creatine monohydrate with whey protein isolate and maltodextrin. It did not test Recharge’s listed combination.

The third objection would be: “Do the added ingredients make Recharge better than plain creatine?”

The answer would say the packet does not contain that comparison.

The additions make the listed composition different. They do not create a verified efficacy advantage in the supplied evidence.

The fourth objection would be: “Will Recharge eliminate soreness or guarantee recovery tomorrow?”

The answer would reject both promises.

The supplied study did not establish those outcomes for Recharge.

The fifth objection would be: “Is it safe for everyone?”

The response would cite NCCIH’s general guidance.

Some supplements may interact with drugs or other supplements. NCCIH advises discussing bodybuilding or endurance supplements with a health care provider.

The execution would clarify that NCCIH did not evaluate Recharge specifically in the supplied source.

Offer

The offer section would remain factual.

It would show the product name, powder format, and three verified serving amounts.

It would not display a price, discount, serving count, guarantee, return period, shipping promise, subscription term, or stock warning.

None of those details was supplied.

A screen note would tell viewers to confirm the current label, directions, warnings, availability, price, and purchase terms on the official product page.

The note would explain that commercial terms can change and must be treated as dated information.

CTA

The call to action, or CTA, would focus on fit rather than urgency.

It would say:

“Consider Recharge if you want the three ingredients Legion lists in one powder. Before buying, confirm the current label and terms. Do not treat the supplied creatine study as proof that the finished formula works better than creatine alone.”

There would be no countdown, scarcity claim, expiring discount, or guaranteed result.

Close

The close would return to the three-label structure:

“One label tells you what is in the serving. One study helps with a narrow creatine-timing question. The remaining evidence gap tells you what not to assume.”

The final screen would summarize the decision.

The creatine form and amount match the study.

The complete Recharge formula does not.

The timing result does not establish a special post-workout advantage.

The two added ingredients remain verified composition facts without supplied outcome evidence.

That would be the complete Daily Intel execution.

Its hook introduces the product-specific comparison between the 5-gram creatine serving and the complete three-ingredient powder.

Its lead gives the viewer a three-part evidence test.

Its story turns assumptions created by the name and composition into questions without inventing a buyer experience.

Its mechanism maps evidence to each ingredient separately.

Its proof uses the supplied primary study rather than social proof.

Its objections address timing, the untested combination, plain creatine, recovery claims, and general safety guidance.

Its offer contains only verified product facts.

Its CTA asks the viewer to make a bounded decision.

The strategy would remain an original Daily Intel narrative model. It would not imply that Legion used it or that any audience responded to it.

Frequently asked questions

Q: What is the main conclusion of this Legion Creatine review?

A: Recharge has a verified 5-gram serving of creatine monohydrate plus two other listed ingredients. Its creatine form and amount match the supplied timing study, but the complete formula was not tested. The packet does not establish that Recharge works better than plain creatine or gains a special advantage from post-workout use.

Q: Was Legion Recharge tested in the supplied clinical study?

A: No. The study tested 5 grams of creatine monohydrate taken within one hour before or after training. Participants also consumed 25 grams of whey protein isolate and 25 grams of maltodextrin with each assigned dose. The researchers did not test Recharge’s three-ingredient formula.

Q: Does Recharge use the same creatine dose as the study?

A: Yes. Recharge lists 5 grams of creatine monohydrate per serving, and the study used 5 grams of creatine monohydrate. This is a direct match for the creatine component only. The complete intervention, study population, and co-ingested nutrients were different.

Q: Must Recharge be taken immediately after a workout?

A: The supplied evidence does not establish that requirement. The study compared creatine taken within one hour before training with creatine taken within one hour after training. Timing had no additional influence on the measured outcomes. The study did not test Recharge, so use should follow the product’s current directions rather than a protocol inferred from the study.

Q: Do L-carnitine L-tartrate and corosolic acid make Recharge better than plain creatine?

A: The packet cannot answer that. Legion lists both ingredients and their amounts, but no supplied study tested whether they improve the effects of creatine or make Recharge more effective than creatine alone.

Q: Does Recharge reduce soreness or guarantee post-workout recovery?

A: The supplied evidence does not establish that Recharge reduces soreness or guarantees post-workout recovery. The supplied study reported fat-free mass, strength, body mass, fat mass, and body fat. The supplied study did not show that Recharge reduces soreness, creates instant recovery, or guarantees next-day readiness.

Q: How much does Legion Recharge cost, and what guarantee is offered?

A: The verified packet does not include a price or guarantee. It also omits serving count, subscription terms, shipping costs, return period, and live availability. Confirm all current commercial terms on the official product page before ordering.

Sources and Evidence Notes

Evidence card: The official Legion Recharge Post-Workout page verifies the product identity and the three listed amounts per serving: 5 grams of creatine monohydrate, 2.1 grams of L-carnitine L-tartrate, and 10.5 milligrams of corosolic acid. It establishes Legion’s listed formula, not an outcome from using it.

Evidence card: The primary study record for PubMed identifier 36465581 reports the eight-week timing study involving 34 healthy, resistance-trained male and female collegiate athletes. Its 5-gram creatine monohydrate intervention matches Recharge’s creatine form and amount. Recharge was not tested, and participants co-ingested 25 grams each of whey protein isolate and maltodextrin.

Evidence card: The NCCIH bodybuilding and performance-enhancement supplement guidance provides general safety context. It notes possible interactions involving some supplements and advises discussing bodybuilding or endurance supplements with a health care provider. It does not establish a Recharge-specific adverse effect or universal safety.

These are the three sources supplied in the verified packet. No outside evidence was added.

Final assessment

Legion Recharge Post-Workout has a clearly defined listed composition.

One serving provides 5 grams of creatine monohydrate, 2.1 grams of L-carnitine L-tartrate, and 10.5 milligrams of corosolic acid, according to Legion Athletics.

The supplied human study matches the creatine form and amount.

That is the strongest link between the product and the research packet.

The study does not match the finished powder.

Participants consumed whey protein isolate and maltodextrin with their assigned doses. Recharge’s L-carnitine L-tartrate and corosolic acid combination was not tested.

The study found no additional influence from creatine timing on its measured outcomes.

That finding does not support a unique post-workout advantage within the tested protocol.

It remains limited to 34 healthy, resistance-trained male and female collegiate athletes studied over eight weeks. The abstract also states that pre-workout versus post-workout timing research is limited.

No supplied evidence establishes that Recharge reduces soreness, guarantees recovery, or works better than plain creatine.

No outcome study was supplied for Recharge’s listed L-carnitine L-tartrate or corosolic acid amounts.

Price, serving count, directions, guarantee, subscription terms, shipping costs, and current availability are also missing.

Recharge may fit someone who specifically wants its documented three-ingredient powder.

It is not verified here as a clinically tested finished formula or a proven timing upgrade.

Confirm the current label, warnings, directions, price, and purchase terms before deciding.

When medication use, other supplements, or individual health concerns matter, discuss the current product label with a qualified health care provider.

Choose Recharge for the composition Legion verifiably lists, not for an added effect or post-workout advantage that the supplied evidence does not establish.

This article is for informational and educational purposes only. It is not medical advice. Daily Intel is not affiliated with or endorsed by Legion Athletics.